Embecta (EMBC) Stock Price, Quote, News & History | Benzinga

Embecta Corp (EMBC) Stock Price, Quote, News & History

EMBCNASDAQ

Trade with Public

Trade with Public

$5.13

0.030.59%

At close: Aug 14, 5:00 PM EST

$5.23

0.132.55%

Pre-Market: 7:00 AM EST

Dividend: The dividend Ex-Date is in 9 days

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

-

Close

$5.13

Volume / Avg.

262.00 / 2.02M

Day Range

- - -

52 Wk Range

2.77 - 15.55

Market Cap

$296.33M

P/E Ratio

3.49

Dividend Yield

0.78%

Exchange

NASDAQ

RSI

75

Short Interest

14.18%

Days to Cover

5.87

Recent Embecta Corp. News

Crude Oil Down 4%; PayPal Shares Fall After Q1 Results

US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.

Avi Kapoor

Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings

US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.

Avi Kapoor

Under the Radar: Why "Fixing" a Great Strategy Usually Breaks It

Tim Melvin

Embecta Rallies After UK Firm Deal Worth $200 Million

Embecta announces $200 million Owen Mumford deal aimed at boosting growth and expanding drug delivery in diabetes and obesity care markets.

Vandana Singh

Why Is Embecta Stock Falling On Friday?

Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

174.10M

Investing Cash Flow (TTM)

-127.80M

Financing Cash Flow (TTM)

-62.30M

Free Cash Flow (TTM)

164.60M

Capital Expenditure (TTM)

-9.50M

Net Change in Cash (TTM)

-16.00M

Analyst Trends and Forecast

1

Apr

2

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

1.8

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.56B

PE Ratio (TTM)

3.49

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

0.30

PB Ratio (TTM)

-

Earnings Yield % (TTM)

28.65%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

5.87

Price / EBITDA (TTM)

1.15

Price / Free Cash Flow (TTM)

1.86

Book Value / Share

-$10.81

Company Debt

Total Debt

$1.46B

LT Debt

$1.32B

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$201.50M

Total Cash

$214.70M

Debt to Equity

-

Issuance of Debt (TTM)

-$21.50M

Repayment of Debt (TTM)

-$201.50M

Key Statistics

Open

-

Close

$5.13

Volume / Avg.

262.00 / 2.02M

Day Range

- - -

52 Wk Range

2.77 - 15.55

Market Cap

$296.33M

P/E Ratio

3.49

Dividend Yield

0.78%

Exchange

NASDAQ

RSI

75

Short Interest

14.18%

Days to Cover

5.87

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, w...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Embecta (EMBC) stock?

A

You can purchase shares of Embecta (NASDAQ:EMBC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Embecta (EMBC) competitors?

A

Other companies in Embecta’s space includes: Alcon Inc (NYSE:ALC), Medline Inc (NASDAQ:MDLN), Solventum Corp (NYSE:SOLV), The Cooper Companies Inc (NASDAQ:COO) and Align Technology Inc (NASDAQ:ALGN).

Q

What is the forecast, or price target, for Embecta (EMBC) stock?

A

Embecta has a consensus price target of $6.67.

Q

What is the current price for Embecta (EMBC)?

A

The stock price for Embecta (NASDAQ: EMBC) is $5.23 last updated August 18, 2026 at 1:19 AM EDT.

Q

Does Embecta (EMBC) pay a dividend?

A

There are no upcoming dividends for Embecta.

Q

When is Embecta (NASDAQ:EMBC) reporting earnings?

A

Embecta does not have any upcoming earnings scheduled.

Q

Is Embecta (EMBC) going to split?

A

There is no upcoming split for Embecta.

Q

What sector and industry does Embecta (EMBC) operate in?

A

Embecta is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.